Cargando…
QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro))
Severe acute respiratory syndrome (SARS) is an illness caused by a novel corona virus wherein the main proteinase called 3CL(Pro) has been established as a target for drug design. The mechanism of action involves nucleophilic attack by Cys145 present in the active site on the carbonyl carbon of the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110475/ https://www.ncbi.nlm.nih.gov/pubmed/18567519 http://dx.doi.org/10.1016/j.jmgm.2008.05.002 |
_version_ | 1783513050090831872 |
---|---|
author | Taranto, Alex G. Carvalho, Paulo Avery, Mitchell A. |
author_facet | Taranto, Alex G. Carvalho, Paulo Avery, Mitchell A. |
author_sort | Taranto, Alex G. |
collection | PubMed |
description | Severe acute respiratory syndrome (SARS) is an illness caused by a novel corona virus wherein the main proteinase called 3CL(Pro) has been established as a target for drug design. The mechanism of action involves nucleophilic attack by Cys145 present in the active site on the carbonyl carbon of the scissile amide bond of the substrate and the intermediate product is stabilized by hydrogen bonds with the residues of the oxyanion hole. Based on the X-ray structure of 3CL(Pro) co-crystallized with a trans-α,β-unsaturated ethyl ester (Michael acceptor), a set of QM/QM and QM/MM calculations were performed, yielding three models with increasingly higher the number of atoms. A previous validation step was performed using classical theoretical calculation and PROCHECK software. The Michael reaction studies show an exothermic process with −4.5 kcal/mol. During the reaction pathway, an intermediate is formed by hydrogen and water molecule migration from a histidine residue and solvent, respectively. In addition, similar with experimental results, the complex between N3 and 3CL(Pro) is 578 kcal/mol more stable than N1-3CL(Pro) using Own N-layer Integrated molecular Orbital molecular Mechanics (ONIOM) approach. We suggest 3CL(Pro) inhibitors need small polar groups to decrease the energy barrier for alkylation reaction. These results can be useful for the development of new compounds against SARS. |
format | Online Article Text |
id | pubmed-7110475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71104752020-04-02 QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) Taranto, Alex G. Carvalho, Paulo Avery, Mitchell A. J Mol Graph Model Article Severe acute respiratory syndrome (SARS) is an illness caused by a novel corona virus wherein the main proteinase called 3CL(Pro) has been established as a target for drug design. The mechanism of action involves nucleophilic attack by Cys145 present in the active site on the carbonyl carbon of the scissile amide bond of the substrate and the intermediate product is stabilized by hydrogen bonds with the residues of the oxyanion hole. Based on the X-ray structure of 3CL(Pro) co-crystallized with a trans-α,β-unsaturated ethyl ester (Michael acceptor), a set of QM/QM and QM/MM calculations were performed, yielding three models with increasingly higher the number of atoms. A previous validation step was performed using classical theoretical calculation and PROCHECK software. The Michael reaction studies show an exothermic process with −4.5 kcal/mol. During the reaction pathway, an intermediate is formed by hydrogen and water molecule migration from a histidine residue and solvent, respectively. In addition, similar with experimental results, the complex between N3 and 3CL(Pro) is 578 kcal/mol more stable than N1-3CL(Pro) using Own N-layer Integrated molecular Orbital molecular Mechanics (ONIOM) approach. We suggest 3CL(Pro) inhibitors need small polar groups to decrease the energy barrier for alkylation reaction. These results can be useful for the development of new compounds against SARS. Elsevier Inc. 2008-10 2008-05-09 /pmc/articles/PMC7110475/ /pubmed/18567519 http://dx.doi.org/10.1016/j.jmgm.2008.05.002 Text en Copyright © 2008 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Taranto, Alex G. Carvalho, Paulo Avery, Mitchell A. QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title | QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title_full | QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title_fullStr | QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title_full_unstemmed | QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title_short | QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro)) |
title_sort | qm/qm studies for michael reaction in coronavirus main protease (3cl(pro)) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110475/ https://www.ncbi.nlm.nih.gov/pubmed/18567519 http://dx.doi.org/10.1016/j.jmgm.2008.05.002 |
work_keys_str_mv | AT tarantoalexg qmqmstudiesformichaelreactionincoronavirusmainprotease3clpro AT carvalhopaulo qmqmstudiesformichaelreactionincoronavirusmainprotease3clpro AT averymitchella qmqmstudiesformichaelreactionincoronavirusmainprotease3clpro |